QPS

Founded in 1995 by Dr. Benjamin Chien, QPS is a global, founder-led contract research organization supporting drug discovery and development from preclinical research through clinical trials. The company serves pharmaceutical and biotechnology sponsors with customized programs designed around each study’s needs, combining scientific expertise, regulatory compliance, and coordinated project ownership.

QPS’s services span bioanalysis, preclinical research, laboratory testing, and clinical development. Its bioanalytical capabilities include small- and large-molecule analysis, genetic medicines, and more than 800 available assays. Preclinical services include DMPK, ADME, drug-drug interaction studies, pharmacology, and toxicology. Laboratory offerings include central safety testing, PBMC services, flow cytometry, genomics, and CLIA-certified capabilities.

For clinical development, QPS provides early- and later-phase trial services, site identification and monitoring, project management, medical writing, pharmacovigilance, regulatory support, biostatistics, data management, recruitment, and real-world evidence studies. The organization also supports multiple therapeutic areas, including oncology, dermatology, rheumatology, vaccines, and women’s health. With operations across the United States, Europe, Asia, and India, QPS offers sponsors a broad range of research expertise and services through a single CRO partner.